Original Research
Published on 27 Jun 2024
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system
in Multiple Sclerosis and Neuroimmunology
- 3,440 views
- 4 citations